Cargando…

Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial

IMPORTANCE: Few interventions are proven to reduce total health care costs, and addressing cost-related nonadherence has the potential to do so. OBJECTIVE: To determine the effect of eliminating out-of-pocket medication fees on total health care costs. DESIGN, SETTING, AND PARTICIPANTS: This seconda...

Descripción completa

Detalles Bibliográficos
Autores principales: Persaud, Nav, Bedard, Michael, Boozary, Andrew, Glazier, Richard H., Gomes, Tara, Hwang, Stephen W., Jüni, Peter, Law, Michael R., Mamdani, Muhammad, Manns, Braden, Martin, Danielle, Morgan, Steven G., Oh, Paul, Pinto, Andrew D., Shah, Baiju R., Sullivan, Frank, Umali, Norman, Thorpe, Kevin E., Tu, Karen, Wu, Fangyun, Laupacis, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220517/
https://www.ncbi.nlm.nih.gov/pubmed/37234014
http://dx.doi.org/10.1001/jamahealthforum.2023.1127
_version_ 1785049236692271104
author Persaud, Nav
Bedard, Michael
Boozary, Andrew
Glazier, Richard H.
Gomes, Tara
Hwang, Stephen W.
Jüni, Peter
Law, Michael R.
Mamdani, Muhammad
Manns, Braden
Martin, Danielle
Morgan, Steven G.
Oh, Paul
Pinto, Andrew D.
Shah, Baiju R.
Sullivan, Frank
Umali, Norman
Thorpe, Kevin E.
Tu, Karen
Wu, Fangyun
Laupacis, Andreas
author_facet Persaud, Nav
Bedard, Michael
Boozary, Andrew
Glazier, Richard H.
Gomes, Tara
Hwang, Stephen W.
Jüni, Peter
Law, Michael R.
Mamdani, Muhammad
Manns, Braden
Martin, Danielle
Morgan, Steven G.
Oh, Paul
Pinto, Andrew D.
Shah, Baiju R.
Sullivan, Frank
Umali, Norman
Thorpe, Kevin E.
Tu, Karen
Wu, Fangyun
Laupacis, Andreas
author_sort Persaud, Nav
collection PubMed
description IMPORTANCE: Few interventions are proven to reduce total health care costs, and addressing cost-related nonadherence has the potential to do so. OBJECTIVE: To determine the effect of eliminating out-of-pocket medication fees on total health care costs. DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis of a multicenter randomized clinical trial using a prespecified outcome took place across 9 primary care sites in Ontario, Canada (6 in Toronto and 3 in rural areas), where health care services are generally publicly funded. Adult patients (≥18 years old) reporting cost-related nonadherence to medicines in the past 12 months were recruited between June 1, 2016, and April 28, 2017, and followed up until April 28, 2020. Data analysis was completed in 2021. INTERVENTIONS: Access to a comprehensive list of 128 medicines commonly prescribed in ambulatory care with no out-of-pocket costs for 3 years vs usual medicine access. MAIN OUTCOME AND MEASURES: Total publicly funded health care costs over 3 years, including costs of hospitalizations. Health care costs were determined using administrative data from Ontario’s single-payer health care system, and all costs are reported in Canadian dollars with adjustments for inflation. RESULTS: A total of 747 participants from 9 primary care sites were included in the analysis (mean [SD] age, 51 [14] years; 421 [56.4%] female). Free medicine distribution was associated with a lower median total health care spending over 3 years of $1641 (95% CI, $454-$2792; P = .006). Mean total spending was $4465 (95% CI, −$944 to $9874) lower over the 3-year period. CONCLUSIONS AND RELEVANCE: In this secondary analysis of a randomized clinical trial, eliminating out-of-pocket medication expenses for patients with cost-related nonadherence in primary care was associated with lower health care spending over 3 years. These findings suggest that eliminating out-of-pocket medication costs for patients could reduce overall costs of health care. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02744963
format Online
Article
Text
id pubmed-10220517
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-102205172023-05-28 Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial Persaud, Nav Bedard, Michael Boozary, Andrew Glazier, Richard H. Gomes, Tara Hwang, Stephen W. Jüni, Peter Law, Michael R. Mamdani, Muhammad Manns, Braden Martin, Danielle Morgan, Steven G. Oh, Paul Pinto, Andrew D. Shah, Baiju R. Sullivan, Frank Umali, Norman Thorpe, Kevin E. Tu, Karen Wu, Fangyun Laupacis, Andreas JAMA Health Forum Original Investigation IMPORTANCE: Few interventions are proven to reduce total health care costs, and addressing cost-related nonadherence has the potential to do so. OBJECTIVE: To determine the effect of eliminating out-of-pocket medication fees on total health care costs. DESIGN, SETTING, AND PARTICIPANTS: This secondary analysis of a multicenter randomized clinical trial using a prespecified outcome took place across 9 primary care sites in Ontario, Canada (6 in Toronto and 3 in rural areas), where health care services are generally publicly funded. Adult patients (≥18 years old) reporting cost-related nonadherence to medicines in the past 12 months were recruited between June 1, 2016, and April 28, 2017, and followed up until April 28, 2020. Data analysis was completed in 2021. INTERVENTIONS: Access to a comprehensive list of 128 medicines commonly prescribed in ambulatory care with no out-of-pocket costs for 3 years vs usual medicine access. MAIN OUTCOME AND MEASURES: Total publicly funded health care costs over 3 years, including costs of hospitalizations. Health care costs were determined using administrative data from Ontario’s single-payer health care system, and all costs are reported in Canadian dollars with adjustments for inflation. RESULTS: A total of 747 participants from 9 primary care sites were included in the analysis (mean [SD] age, 51 [14] years; 421 [56.4%] female). Free medicine distribution was associated with a lower median total health care spending over 3 years of $1641 (95% CI, $454-$2792; P = .006). Mean total spending was $4465 (95% CI, −$944 to $9874) lower over the 3-year period. CONCLUSIONS AND RELEVANCE: In this secondary analysis of a randomized clinical trial, eliminating out-of-pocket medication expenses for patients with cost-related nonadherence in primary care was associated with lower health care spending over 3 years. These findings suggest that eliminating out-of-pocket medication costs for patients could reduce overall costs of health care. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02744963 American Medical Association 2023-05-26 /pmc/articles/PMC10220517/ /pubmed/37234014 http://dx.doi.org/10.1001/jamahealthforum.2023.1127 Text en Copyright 2023 Persaud N et al. JAMA Health Forum. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Persaud, Nav
Bedard, Michael
Boozary, Andrew
Glazier, Richard H.
Gomes, Tara
Hwang, Stephen W.
Jüni, Peter
Law, Michael R.
Mamdani, Muhammad
Manns, Braden
Martin, Danielle
Morgan, Steven G.
Oh, Paul
Pinto, Andrew D.
Shah, Baiju R.
Sullivan, Frank
Umali, Norman
Thorpe, Kevin E.
Tu, Karen
Wu, Fangyun
Laupacis, Andreas
Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial
title Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial
title_full Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial
title_fullStr Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial
title_full_unstemmed Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial
title_short Effect of Free Medicine Distribution on Health Care Costs in Canada Over 3 Years: A Secondary Analysis of the CLEAN Meds Randomized Clinical Trial
title_sort effect of free medicine distribution on health care costs in canada over 3 years: a secondary analysis of the clean meds randomized clinical trial
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10220517/
https://www.ncbi.nlm.nih.gov/pubmed/37234014
http://dx.doi.org/10.1001/jamahealthforum.2023.1127
work_keys_str_mv AT persaudnav effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT bedardmichael effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT boozaryandrew effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT glazierrichardh effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT gomestara effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT hwangstephenw effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT junipeter effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT lawmichaelr effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT mamdanimuhammad effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT mannsbraden effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT martindanielle effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT morgansteveng effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT ohpaul effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT pintoandrewd effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT shahbaijur effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT sullivanfrank effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT umalinorman effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT thorpekevine effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT tukaren effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT wufangyun effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial
AT laupacisandreas effectoffreemedicinedistributiononhealthcarecostsincanadaover3yearsasecondaryanalysisofthecleanmedsrandomizedclinicaltrial